ArticleClinical and translational science2019

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor.

Jim J Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.